Black Bird Biotech BBBT · USD

Its shares trade under the ticker BBBT. It has been listed since 10 December 2007. In the fiscal year to 31 December 2023, it reported revenue of $36,323 and a net loss of $836,135.

Black Bird Biotech, Inc. engages in the manufacture and sale of cannabidiol products through its subsidiary, Black Bird Potentials, Inc. Its products include MiteXstream, Grizzly Creek Naturals, and Black Bird American Hemp. The company is headquartered in Argyle, Texas. The company went IPO on 2007-12-10. The firm also manufactures and sells, under its Grizzly Creek Naturals brand name, cannabidiol (CBD) products, including CBD Oils, gummies and pet treats, as well as CBD-infused personal care products. Big Sky American Dist., LLC (Big Sky American) distributes its Grizzly Creek Naturals products, as well as an array of other consumer retail products, in Western Montana. The firm's subsidiaries include Black Bird Potentials Inc. (BB Potentials), Big Sky American Dist., LLC (Big Sky American) and Black Bird Hemp Manager, LLC.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Fabian DeneaultChairman of the Board, President, since 2020$70,692
• Mr. Nelson GristChief Executive Officer
• Mr. William SlussChief Financial Officer, Vice President - Finance, Director, since 2011$26,500
• Mr. William LobellExecutive Vice President of Sales and Development
• Mr. Eric NewlanVice President, Secretary, Director, since 2020$85,010
• Mr. L. A. NewlanDirector
• Mr. Jack QinDirector

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.